Skip to main content
Clinical Trials/ISRCTN27208571
ISRCTN27208571
Completed
未知

To compare selective laser trabeculoplasty (SLT) with prostaglandin analogue as first line therapy in African Primary Open Angle Glaucoma (POAG) patients

niversity College London0 sites571 target enrollmentDecember 14, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Primary open-angle glaucoma
Sponsor
niversity College London
Enrollment
571
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 14, 2015
End Date
November 30, 2018
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity College London

Eligibility Criteria

Inclusion Criteria

  • 1\. Consent to inclusion and participation in trial
  • 2\. Characteristic glaucomatous changes in the optic disc. The presence of a focal or diffuse area of optic disc rim loss, so that the neuroretinal rim tissue in any quadrant is less than 5% of the disc diameter in that meridian. Extensive loss of neuroretinal rim tissue with marked optic disc cupping giving a cup disc ratio greater than 0\.6
  • 3\. A measured intraocular pressure greater than or equal to 21 mmHg and less than or equal to 30mmHg on at least one visit before the time of entry into the study as measured by Goldmann applanation tonometry
  • 4\. Adequate visualization of angle structures (i.e. clear media and cooperative patient)
  • 5\. Black African patients

Exclusion Criteria

  • 1\. Unwillingness to participate in the study
  • 2\. Inability/unwillingness to give informed consent
  • 3\. Unwillingness to accept randomisation
  • 4\. Patient less than 20 years of age
  • 5\. Anterior segment neovascularisation
  • 6\. Past trauma to the eye or ocular adnexae
  • 7\. Retinal or optic nerve neovascularisation
  • 8\. Aphakia or pseudophakia
  • 9\. Previous ocular surgery Evidence of ocular disease other than glaucoma that might affect the measurements of IOP, assessment of visual function, visual field testing would likely require cataract surgery within 12 months of randomization on systemic medications known to ­IOP (e.g. steroids) Pregnancy or female of childbearing age who may be pregnant at time of treatment (LMP).
  • 10\. Anyone who is not Black African race

Outcomes

Primary Outcomes

Not specified

Similar Trials